Divik Seth joins Salus Wellness
We are very pleased to announce that Divik Seth has joined Salus Wellness this month.
Biodesix partner - Friends of Cancer Research, publishes study linking ctDNA changes to solid tumour treatment outcomes
Aggregate analysis of eight clinical trials of patients with advanced non-small cell lung cancer (aNSCLC) was supported by Biodesix, using Bio-Rad Droplet Digital™ PCR technology
Mursla Bio receives FDA breakthrough device designation for EvoLiver Test
Reflects the potential of EvoLiver test to improve early liver cancer detection among high-risk patients EvoLiver leverages Mursla Bio’s platform based on organ-specific extracellular vesicles circulating in blood Breakthrough status provides
Wilson Connectivity introduces industry-leading public safety solutions to revolutionize emergency response communications
Wilson Connectivity, a leader in wireless communication technology, announces the launc
An Adventurous Biotech CEO
Priya Mande, CEO of RNAvate, is leading the discussion on Biotech and Partnering Hotspots at BioBeat25. Organisers Anne Horgan, Partner at Cambridge Innovation Capital, Alisa Molotova, Start-up Mentor and Miranda Weston-Smith, BioBeat Founder quiz her about how she got into her role.
Nuria Segarra joins Salus Wellness
The team are very pleased to announce that Dr Nuria Segarra has joined Salus Wellness this month.
Wilson Connectivity: Interview with CEO Bruce Lancaster about the wireless communication leader
Wilson Connectivity is the home of WilsonPro, weBoost, and Zinwave, and it is the market leader in in-building wireless communication technology.
New collaboration to uncover how the hidden language of genes shapes our immune system
A major new initiative, launched on 15 April, will map how gene activity shapes the immune system, and could help identify new therapeutic targets for conditions such as Inflammatory Bowel Disease (IBD).
Atelerix signs exclusive agreement with MineBio to establish distribution channel for non-cryogenic cell preservation solutions in China
Partnership with specialist life science distributor establishes sales channel in high-demand market and strengthens global networkHypothermic preservation technology eliminates costs and inefficiencies of cold-chain logistics to enhance biomedical research and cell the
Killer50 companies raise megabucks in Q1 2025
Business Weekly newsdesk writes: Seven companies in The Killer50 pantheon compiled by Business Weekly have collectively raised almost $1/2 billion in the first quarter of 2025 alone. Two were in our Technology top 50 and five in the Life Sciences cohort.
A smarter IT solution for schools – now all in one place
Breathe Technology is proud to be the authorised support partner for Schools Broadband in Peterborough.
Nuclera expands eProtein Discovery capabilities to enable membrane protein production
Membrane proteins synthesized and purified within 48 hours. Active membrane transporter, MsbA and integral membrane protein, ZMPSTE24 synthesizedCambridge, UK, and Boston MA, USA, 14 April 2025: Nuclera, the biotechnology company
25 years of Guardtech: Q&A with Projects Director Conor Barwise
‘Mr. Guardtech’ on how he helped lead Guardtech Cleanrooms in a new direction to become a leading light in UK controlled environment construction.
42 Technology and Addenbrooke’s Hospital develop AI innovation to improve newborn eye screening
42 Technology is helping Cambridge University Hospitals NHS Foundation Trust (CUH) to develop an advanced AI feature for a groundbreaking hand-held newborn eye screening device.
Strengthening human factors leadership to drive user-centred design innovation
At Team Consulting, we have been working at the forefront of human factors since 1999, helping our clients to create medical products that are not only
Rapid growth of blood cancer driven by a single genetic 'hit'
A new study has unveiled when chronic myeloid leukaemia, a type of cancer that affects the blood and bone marrow, arises in life and how fast it grows. Researchers reveal explosive growth rates of cancerous cells years before diagnosis and variation in these rates of growth between patients. Such rapid growth rates had previously not been observed in most other cancers.
Cambridge Cognition Secures £1million Contract for Phase 3 Autoimmune Disease Trial
Cambridge Cognition (AIM: COG), the brain health software group specialising in digital products to advance clinical research and patient treatment, has been selected by a major pharmaceutical company to provide digital cognitive assessments for a large Phase 3 autoimmune disease clinical trial. The initial contract, starting in 2025 and running through to 2031, is valued at approximately £1…
Milner Institute signs MOU with Yonsei University for joint research in quantum computing
The agreement is expected to serve as a critical foundation for activating international joint research, academic exchange and research collaboration in quantum fields, including quantum computing.
Milner Institute delivers Cambridge-Google AlphaFold Workshop
The workshop brought together leading academic researchers, industry experts and innovators to explore the fundamentals of AlphaFold – an artificial intelligence (AI) program developed by Google DeepMind to predict the 3D structure of proteins.
The role of AI and omnichannel strategies in healthcare marketing
Co-authored by Jose Maria (Chema) Guido Avila, Sanofi
Sphere Bio expands APAC distribution network to strengthen presence in region
Operational scale-up accelerates global growth strategy to increase regional access and technical support
The 8Cs of smart business expansion: A simple framework for going big, the right way
By Gary Jennings, Innovation Director, The EpiCentre.
World-first trial indicates immunosuppression may help treat Parkinson’s
A groundbreaking trial, led from Cambridge, has revealed that immunosuppressing medicines show promise for the treatment of Parkinson’s disease, according to results presented this weekend at the world’s most prestigious neurodegeneration conference AD/PD.
ELRIG appoints Dr Del Trezise as Chair
Cambridge, UK, 8 April 2025: ELRIG, a not-for-profit, volunteer-led organisation dedicated to the drug discovery community, has appointed Dr Del Trezise as Chair of the Board.
IBL International collaborates with Grifols on advanced biomarker panels
Grifols and IBL, a Tecan company, seek to revolutionize clinical diagnostics with a future high-sensitivity, multiplexed immunoassay platform